Summary
This network meta-analysis examined nonpharmacologic therapies for depressive symptoms in patients with chronic fatigue syndrome (CFS). The authors searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, Wanfang, CBM, VIP, and Sinomed for randomized controlled trials until March 26, 2025, and included 47 RCTs involving 4,028 participants. The review compared nonpharmacologic interventions with control conditions and measured depression or depressive symptoms with scales. Compared with control, the review reports significant differences for acupuncture (SMD = -1.91, 95% CI: -2.9 to -0.94), moxibustion (SMD = -2.91, 95% CI: -4.61 to -1.22), Tuina (SMD = -2, 95% CI: -3.64 to -0.38), diet therapy (SMD = -5.64, 95% CI: -8.98 to -2.29), electrical stimulation (SMD = 1.9, 95% CI: 0.03 to 3.78), Ap + Mox (SMD = 2.53, 95% CI: 1.17 to 3.91), and Ap + Mox + Ae (SMD = 3.16, 95% CI: 0.39 to 5.98). The review states that relaxation therapy, AER, RT, and Qigong did not markedly improve depressive symptoms, and psychotherapy did not show significant effects. Harms were not reported as counts; the review includes a statement that graded exercise therapy may exacerbate symptoms in certain CFS patients, a statement about exercise therapy, the patient’s energy limit, characteristic post-exertional malaise (PEM), and efficacy, and a statement that Tuina has no adverse reactions. The authors state heterogeneity, inconsistent depression scales, and medium risk of bias in most included studies, with some interventions from few small studies, so results should be viewed with caution.